BWV

iPath ETN linked to CBOE S&P 500 Buy Write Index

BWV

Market cap $7.75M

Overview Fund Activity

Delisted

BWV was delisted on the 12th of April, 2018.

Back to rankings

Financial journalist opinion

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: BWV) ("Onconetix" or the “Company”) today issued the following shareholder letter from the Company's Chief Executive Officer, Dr. Neil Campbell.

Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer Transaction strengthens commercial business with addition of diagnostics product and initial focus on prostate cancer

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™

See News Rankings

Charts implemented using Lightweight Charts™